Form 8-K - Current report:
SEC Accession No. 0001087294-14-000019
Filing Date
2014-05-09
Accepted
2014-05-09 17:15:42
Documents
5
Period of Report
2014-05-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8kstubforcetinvestmentand.htm 8-K 28340
2 EXHIBIT 99.1 CET INVESTMENT exhibit991-cetinvestment.htm EX-99.1 18610
3 EXHIBIT 99.2 VAPRISOL LAUNCH exhibit992-vaprisollaunch.htm EX-99.2 20534
4 cumberlandpicture.jpg GRAPHIC 35104
5 newgloriapicture.jpg GRAPHIC 23895
  Complete submission text file 0001087294-14-000019.txt   150045
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 14830175
SIC: 2834 Pharmaceutical Preparations